brain neoplasm: A neoplasm (disease) that involves the brain.
Benign neoplasm of brain and other parts of central nervous system
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_BRAIN_CNS
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
2267 |
4. Check minimum number of eventsNone |
2267 |
5. Include endpoints |
2479 |
6. Filter based on genotype QC (FinnGen only) |
2479 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna systematis nervosi centralis et nervorum cranialium
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of brain and other parts of central nervous system
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 16990 | 9327 | 7538 |
| Only index persons | 14502 | 8017 | 6485 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.24 | 0.27 | 0.21 |
| Only index persons | 0.27 | 0.29 | 0.25 |
| Median age at first event (years) | |||
| Whole population | 52.95 | 54.19 | 51.37 |
| Only index persons | 51.94 | 53.03 | 50.59 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2479 | 1413 | 1066 |
| Unadjusted period prevalence (%) | 0.48 | 0.48 | 0.47 |
| Median age at first event (years) | 53.69 | 52.19 | 55.68 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2228
- Matched controls
- 22280
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
11.9
323.0
689
809
D33.30
ICD-10 Finland
Acoustic neuroma
10818.7
323.0
744
*
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
90.8
323.0
507
72
D33.45
ICD-10 Finland
Benign Schwannom in the nerve root of the spinal cord
+∞
258.5
243
*
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
+∞
229.2
216
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
33.5
211.4
280
95
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
245.2
198.1
201
9
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
191.5
181
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
38.4
171.0
219
63
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
1442.6
140.1
135
*
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
130.5
124
*
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
23.2
124.5
182
85
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
8.4
112.1
260
343
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.9
105.3
383
908
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
9.4
102.9
223
261
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
33.3
100.0
132
42
DFF00
NOMESCO Finland
Pure tone audiometry
4.4
94.3
386
1023
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
477.0
93.0
92
*
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
+∞
92.3
88
*
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
92.3
88
*
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
21.2
89.4
134
67
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
29.9
87.8
119
42
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
+∞
84.9
81
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
84.9
81
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
81.8
78
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
81.8
78
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
+∞
79.7
76
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.5
79.6
252
503
AA1AD
NOMESCO Finland
CT of head and brain
2.7
79.5
703
3267
ABB10
NOMESCO Finland
Resection of lesion of spinal canal
406.5
79.4
79
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
94.6
74.4
82
9
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.9
71.7
526
2158
D33.43
ICD-10 Finland
Spinal cord
+∞
71.2
68
*
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
710.0
70.5
69
*
2152
FHL
Extraction, big brain
98.3
69.3
76
8
D33.4
ICD-10 Finland
Benign neoplasm: Spinal cord
+∞
69.1
66
*
9560/0-C72.0
ICD-O-3
Schwannoma, NOS, of spinal cord
688.7
68.4
67
*
22500
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
68.1
65
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
8.5
66.8
152
191
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
61.7
59
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.9
61.5
441
1765
G91.1
ICD-10 Finland
Obstructive hydrocephalus
50.2
60.6
73
15
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
59.6
57
*
N03AF02
ATC
oxcarbazepine; oral
6.1
59.0
168
292
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
24.4
54.8
78
33
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
54.4
52
*
D33.14
ICD-10 Finland
Hemangioblastoma and cerebellum
+∞
52.3
50
*
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
27.7
51.0
70
26
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.5
50.1
449
2022
22510
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves (including optic)
+∞
49.1
47
*
D33.47
ICD-10 Finland
Other benign neurofibromas in the nerve root of the spinal cord
+∞
49.1
47
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
48.8
702
3969
DFF15
NOMESCO Finland
Speech audiometry
4.5
48.4
181
428
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
130.4
48.0
51
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
47.0
45
*
DFF59
NOMESCO Finland
Other assessment of balance
13.5
46.1
81
62
9161/1-C71.6
ICD-O-3
Hemangioblastoma of cerebellum, NOS
+∞
46.0
44
*
N03AX14
ATC
levetiracetam; systemic
6.4
45.8
125
205
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
7.9
45.4
107
142
R51.80
ICD-10 Finland
Headache
2.5
45.2
404
1805
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
13.6
45.1
79
60
G51.0
ICD-10 Finland
Bell palsy
5.8
42.9
127
231
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.4
42.9
105
148
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
56.8
42.5
50
9
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
6.7
41.6
109
169
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.3
41.0
161
398
H02AB02
ATC
dexamethasone; systemic
2.7
39.5
291
1160
D33.15
ICD-10 Finland
Another benign tumor of the cerebellum
+∞
38.6
37
*
9560/0-C72.5
ICD-O-3
Schwannoma, NOS, of cranial nerve, NOS
+∞
38.6
37
*
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
37.6
36
*
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.9
37.4
81
94
AAE34
NOMESCO Finland
Other operations on acoustical nerv
373.3
37.1
37
*
N03AF01
ATC
carbamazepine; oral, rectal
3.6
37.0
177
521
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
26.0
36.8
51
20
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
9.6
36.6
76
82
ZXC40
NOMESCO Finland
Use of ultrasound
12.6
36.5
66
54
H02.2
ICD-10 Finland
Lagophthalmos
26.9
36.4
50
19
9560/0-C72.9
ICD-O-3
Schwannoma, NOS, of nervous system, NOS
+∞
35.5
34
*
D33.11
ICD-10 Finland
Brain stem
+∞
35.5
34
*
ZXC95
NOMESCO Finland
Use of surgical navigator
8.6
35.2
78
94
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
34.5
33
*
D33.41
ICD-10 Finland
Myxopapillary epndymoma of the spinal cord (grade I)
+∞
34.5
33
*
XA800
NOMESCO Finland
Neuropsychological investigation
3.8
33.0
145
397
R42
ICD-10 Finland
Dizziness and giddiness
2.0
32.9
514
2924
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
32.8
411
2133
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
6.8
32.8
84
127
G93.0
ICD-10 Finland
Cerebral cysts
18.2
32.3
50
28
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
8.8
32.2
70
82
D36.1
ICD-10 Finland
Benign neoplasm: Peripheral nerves and autonomic nervous system
26.4
31.9
44
17
D43.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Spinal cord
73.3
31.9
36
5
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
37.0
31.5
40
11
D33.12
ICD-10 Finland
Cerebellum
+∞
31.3
30
*
C71.60
ICD-10 Finland
Malignant tumor of cerebellum without histology
+∞
31.3
30
*
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
23.6
31.0
44
19
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
111.6
30.7
33
*
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
52.2
30.4
36
7
N07CA01
ATC
betahistine; oral
2.8
30.3
210
802
D33.46
ICD-10 Finland
Benign neurofibroma in the nerve root of the spinal cord
+∞
30.3
29
*
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
9.4
30.2
63
69
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
14.1
29.9
51
37
XCK00
NOMESCO Finland
Perimetry
2.8
29.3
199
748
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
4.8
28.5
97
208
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.9
28.5
120
317
H93.1
ICD-10 Finland
Tinnitus
2.8
27.5
185
690
WF099
NOMESCO Finland
Other radiotherapy
13.7
27.3
47
35
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
30.5
27.2
36
12
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
46.3
26.5
32
7
R4110
NOMESCO Finland
Physiotherapy
1.8
26.3
603
3869
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
6.8
26.3
67
101
N03AX12
ATC
gabapentin; oral
2.0
26.2
353
1874
N03AB02
ATC
phenytoin; systemic
7.7
25.6
60
80
D33.04
ICD-10 Finland
Temporal lobe
+∞
25.0
24
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
25.0
472
2838
TAB00
NOMESCO Finland
Lumbar puncture
3.2
24.8
133
427
9530/0-C70.1
ICD-O-3
Meningioma, NOS, of spinal meninges
131.5
24.6
26
*
N76
ICPC
Neoplasm nervous system unspecified
43.4
24.6
30
7
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.4
24.1
74
142
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
24.0
23
*
D33.42
ICD-10 Finland
Hemangioblastoma of the spinal cord
+∞
24.0
23
*
N75
ICPC
Benign neoplasm nervous system
68.2
23.8
27
*
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
31.4
23.7
31
10
N03AX16
ATC
pregabalin; oral
1.8
23.6
519
3270
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.4
23.4
207
905
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
22.9
22
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
30.4
22.8
30
10
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
7.5
22.4
53
72
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
24.1
22.2
31
13
Q85.09
ICD-10 Finland
Unspecified neurofibromatosis
35.4
22.1
28
8
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
18.6
21.7
33
18
DE2CM
NOMESCO Finland
Acoustic channel extensive MRI examination with 3 Tesla magnet
22.4
21.7
31
14
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
8.3
21.7
48
59
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
8.5
21.1
46
55
D33.1
ICD-10 Finland
Benign neoplasm: Brain, infratentorial
+∞
20.9
20
*
9391/3-C72.0
ICD-O-3
Ependymoma, NOS, of spinal cord
+∞
20.9
20
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.8
20.2
135
502
G91.0
ICD-10 Finland
Communicating hydrocephalus
10.4
20.1
39
38
E23.00
ICD-10 Finland
Panhypopituitarism
11.4
20.0
37
33
H53.4
ICD-10 Finland
Visual field defects
4.3
19.9
75
180
9394/1-C72.0
ICD-O-3
Myxopapillary ependymoma of spinal cord
+∞
19.8
19
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
8.4
19.7
43
52
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
106.0
19.6
21
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
106.0
19.6
21
*
D32.05
ICD-10 Finland
Cerebral meninges
24.8
19.5
27
11
N02BE01
ATC
paracetamol; systemic, rectal
1.7
19.3
1834
16422
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.1
19.2
43
54
WX110
NOMESCO Finland
Local anesthesy
1.5
19.1
1435
12118
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.1
19.0
240
1230
101
Kela drug reimbursment
Anterior pituitary hypofunction
8.5
18.9
41
49
9421/1-C71.6
ICD-O-3
Pilocytic astrocytoma of cerebellum, NOS
+∞
18.8
18
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
8.3
18.7
41
50
WX882
NOMESCO Finland
High dependency care
3.5
18.6
88
258
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.7
18.6
82
227
S18
ICPC
Laceration/cut
1.5
18.5
860
6520
H53.2
ICD-10 Finland
Diplopia
3.4
18.3
91
278
ZZC00
NOMESCO Finland
Graft of fascia
44.4
18.2
22
5
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
17.7
18.2
28
16
183
Kela drug reimbursment
Lamotrigin and topiramate
7.1
18.1
44
63
H02AB09
ATC
hydrocortisone; systemic
3.9
18.1
76
202
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
52.9
18.0
21
*
H47.2
ICD-10 Finland
Optic atrophy
13.1
17.9
31
24
NA3DG
NOMESCO Finland
Lumbar spine very extensive MRI examination with high intensity magnet
10.1
17.9
35
35
D33
ICD-10 Finland
Benign neoplasm of brain and other parts of central nervous system
+∞
17.7
17
*
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
17.7
17
*
2259X
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Nervous system, part unspecified
+∞
17.7
17
*
N03AX18
ATC
lacosamide; systemic
10.4
17.7
34
33
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
37.0
17.6
22
6
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.6
17.1
488
3272
SPAT1153
SPAT
Removal of sutures
1.5
17.0
671
4876
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
13.3
16.9
29
22
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.6
16.9
127
508
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
16.8
224
1177
22520
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
171.2
16.5
17
*
N03AG01
ATC
valproic acid; systemic, rectal
2.4
16.5
148
650
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
47.8
16.0
19
*
R5120
NOMESCO Finland
Preparation of an aid
3.5
16.0
74
214
G40.10
ICD-10 Finland
Simple partial seizures
8.3
16.0
35
43
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
3.8
15.8
67
180
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
60.4
15.8
18
*
NA2DG
NOMESCO Finland
Thoracal spine very extensive MRI examination with high intensity magnet
33.6
15.7
20
6
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
6.5
15.7
40
62
2151
FHL
Resection, big brain
85.7
15.6
17
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.0
15.4
197
1014
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.2
15.3
161
763
A02BC02
ATC
pantoprazole; systemic
1.4
15.3
1312
11112
WX402
NOMESCO Finland
General anaesthesia
1.7
15.2
352
2219
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
28.8
15.2
20
7
AAF00
NOMESCO Finland
Ventriculostomy
7.5
15.2
35
47
ACB19
NOMESCO Finland
Excision of lesion of peripheral nerve other or unspecified
20.2
15.1
22
11
N05BA09
ATC
clobazam; oral
8.5
15.0
32
38
N02AX02
ATC
tramadol; systemic, rectal
1.5
14.9
840
6544
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.0
14.9
85
286
L01AX03
ATC
temozolomide; systemic
8.0
14.8
33
42
YX8AD
NOMESCO Finland
Stereotactic CT examination for dose design of radiotherapy
57.1
14.8
17
*
2312
FHL
Extirpation or destruction
57.1
14.8
17
*
D43.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other parts of central nervous system
57.1
14.8
17
*
ZXC86
NOMESCO Finland
Use of endoscopic device
11.4
14.8
27
24
UDC00
NOMESCO Finland
Ear microscopy
2.1
14.4
161
785
G50.0
ICD-10 Finland
Trigeminal neuralgia
4.2
14.3
53
127
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
6.8
14.2
35
52
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
13.5
14.2
24
18
Z31.5
ICD-10 Finland
Genetic counselling
2.5
14.2
114
475
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
12.8
13.9
24
19
Q85.1
ICD-10 Finland
Tuberous sclerosis
53.7
13.8
16
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
7.4
13.7
32
44
Q85.0
ICD-10 Finland
Neurofibromatosis (nonmalignant)
75.6
13.6
15
*
8000/0-C72.4
ICD-O-3
Neoplasm, benign of acoustic nerve
+∞
13.6
13
*
22530
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
13.6
13
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
16.3
13.4
21
13
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.5
13.4
34
53
L28
ICPC
Limited function/disability (L)
1.7
13.3
317
2010
D32.03
ICD-10 Finland
Benign meningioma in ventricles
21.3
13.3
19
9
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
13.0
810
6392
CBH25
NOMESCO Finland
Tarsorrhaphy
28.5
13.0
17
6
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
22.7
12.9
18
8
CBH30
NOMESCO Finland
Tarsorraphy
50.3
12.8
15
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
2.1
12.8
139
670
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
4.6
12.7
43
95
C72.01
ICD-10 Finland
Malignant tumor of the spinal cord grade II glioma
+∞
12.5
12
*
D33.17
ICD-10 Finland
Fourth ventricle
+∞
12.5
12
*
C72.09
ICD-10 Finland
Malignant tumor of the spinal cord other histology
130.7
12.4
13
*
ZXA05
NOMESCO Finland
Left side
1.5
12.4
511
3704
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.9
12.2
178
965
XKD00
NOMESCO Finland
Uroflowmetry
1.6
12.1
299
1916
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.1
12.1
131
631
G44.2
ICD-10 Finland
Tension-type headache
1.7
11.9
256
1576
2159
FHL
Other measure in this category
46.9
11.9
14
*
DE2BM
NOMESCO Finland
Acoustic channel MRI examination with 3 Tesla magnet
46.9
11.9
14
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
46.9
11.9
14
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
3.0
11.8
67
226
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.7
11.7
243
1481
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
30.2
11.6
15
5
23810
ICD-8 Finland
Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain
65.3
11.6
13
*
C72.00
ICD-10 Finland
Malignant tumor of the spinal cord without histology
65.3
11.6
13
*
N03AX11
ATC
topiramate; oral
3.2
11.5
60
193
2253A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Spinal cord
+∞
11.5
11
*
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
11.5
11
*
9161/1-C72.0
ICD-O-3
Hemangioblastoma of spinal cord
+∞
11.5
11
*
3252
FHL
Repair with foreign material (spring, magnet)
+∞
11.5
11
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
4.8
11.5
37
78
R20.2
ICD-10 Finland
Paraesthesia of skin
2.1
11.4
125
607
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
11.3
214
1266
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
15.1
11.3
18
12
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
8.4
11.3
24
29
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
8.1
11.1
24
30
WF002
NOMESCO Finland
Radical radiotherapy
2.2
11.0
114
537
R51
ICD-10 Finland
Headache
2.2
11.0
109
503
A06AD11
ATC
lactulose; oral
1.7
11.0
263
1668
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
10.9
209
1240
G91.8
ICD-10 Finland
Other hydrocephalus
43.5
10.9
13
*
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
43.5
10.9
13
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
10.9
287
1869
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.8
10.9
24
31
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
9.6
10.7
21
22
N18
ICPC
Paralysis/weakness
3.5
10.7
49
143
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
28.2
10.7
14
5
N03AX09
ATC
lamotrigine; oral
2.3
10.7
94
412
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
60.3
10.6
12
*
AAH50
NOMESCO Finland
Cranial nerve anastomosis
60.3
10.6
12
*
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
60.3
10.6
12
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
10.4
848
6932
AAF50
NOMESCO Finland
Third ventriculostomy
+∞
10.4
10
*
22599
ICD-8 Finland
Benign neoplasm of brain and other parts of nervous system, Unspecified site
+∞
10.4
10
*
G91.2
ICD-10 Finland
Normal-pressure hydrocephalus
4.2
10.3
38
92
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
10.2
153
840
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
13.2
10.2
17
13
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
5.2
10.1
30
58
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
10.1
60
212
QAJ10
NOMESCO Finland
Browlift
9.2
10.0
20
22
H16.0
ICD-10 Finland
Corneal ulcer
2.2
9.9
97
449
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
2.3
9.8
93
423
R13
ICD-10 Finland
Dysphagia
2.0
9.7
129
677
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
7.4
9.7
22
30
N05BA01
ATC
diazepam; systemic, rectal
1.6
9.7
256
1665
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
9.6
234
1492
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
11.4
9.6
17
15
TAA40
NOMESCO Finland
Cathetrisation of cerebrospinal fluid through skin
10.1
9.5
18
18
N03AE01
ATC
clonazepam; systemic
2.0
9.5
117
596
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
30.1
9.4
12
*
AAF15
NOMESCO Finland
Ventriculoatrial shunt
17.6
9.4
14
8
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
9.4
9
*
CBK99
NOMESCO Finland
Other operation for retraction of eyelid
+∞
9.4
9
*
2396A
ICD-9 Finland
Neoplasm of unspecified nature, Brain
+∞
9.4
9
*
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
9.4
9
*
AWW99
NOMESCO Finland
Other reoperation in surgery of the nervous system
+∞
9.4
9
*
C75.3
ICD-10 Finland
Malignant neoplasm: Pineal gland
+∞
9.4
9
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
9.4
394
2850
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
12.4
9.4
16
13
H81.3
ICD-10 Finland
Other peripheral vertigo
2.7
9.3
63
241
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.8
9.3
170
997
AA1AA
NOMESCO Finland
Head X-ray examination
5.0
9.2
28
56
M03BX01
ATC
baclofen; systemic
3.3
9.2
44
134
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.5
9.2
70
286
DAX08
NOMESCO Finland
Fitting of hearing aid
2.2
9.2
89
409
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.6
9.2
276
1857
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.2
9.2
87
398
SPAT1043
SPAT
Audiometry
1.7
9.1
196
1207
H47.1
ICD-10 Finland
Papilloedema, unspecified
7.7
9.1
20
26
H49.1
ICD-10 Finland
Fourth [trochlear] nerve palsy
6.3
9.1
23
37
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
11.5
9.1
16
14
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
5.9
9.0
24
41
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
4.7
9.0
29
62
2132
FHL
Ventricular operators sunt
36.8
9.0
11
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
7.1
9.0
21
30
R4120
NOMESCO Finland
Occupational therapy
1.9
9.0
128
691
R5140
NOMESCO Finland
Monitoring the use of the aid
1.7
8.9
199
1239
R51.81
ICD-10 Finland
Facial pain NOS
3.0
8.9
49
166
119
Kela drug reimbursment
Trigeminal neuralgia or glossofaryngeusneuralgia
8.0
8.8
19
24
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
8.7
413
3058
D35.30
ICD-10 Finland
Craniopharyngoma
50.2
8.7
10
*
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
6.2
8.6
22
36
R4150
NOMESCO Finland
Neuropsychological rehabilitation
5.3
8.6
25
48
N28
ICPC
Limited function/disability (N)
3.5
8.6
38
110
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
10.1
8.5
16
16
D48.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Peripheral nerves and autonomic nervous system
27.6
8.5
11
*
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
8.5
201
1274
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
20.1
8.5
12
6
2130
FHL
Ventricular atrial shunt
90.4
8.4
9
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.9
8.4
117
627
D42.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Meninges, unspecified
+∞
8.3
8
*
C71.6
ICD-10 Finland
Malignant neoplasm: Cerebellum
+∞
8.3
8
*
1922A
ICD-9 Finland
Malignant neoplasm of other and unspecified parts of nervous system, Spinal cord
+∞
8.3
8
*
N99
ICPC
Neurological disease other
3.9
8.3
32
82
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.4
8.3
65
271
CBW99
NOMESCO Finland
Other operation on eyelid
33.5
8.1
10
*
AWC00
NOMESCO Finland
Reoperation of nervous system because of deep wound infection in the nervous system
33.5
8.1
10
*
ZZK00
NOMESCO Finland
Graft of nerve
33.5
8.1
10
*
SPAT1229
SPAT
Assessment of need for aid
1.8
8.1
142
823
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
3.6
8.0
34
95
N06AA09
ATC
amitriptyline; systemic
1.6
8.0
187
1178
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.5
8.0
60
245
G00.9
ICD-10 Finland
Bacterial meningitis, unspecified
10.1
8.0
15
15
N88
ICPC
Epilepsy
5.3
8.0
23
44
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
8.0
49
179
H50.2
ICD-10 Finland
Vertical strabismus
5.9
8.0
21
36
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
7.8
7.9
17
22
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.8
234
1573
QAJ20
NOMESCO Finland
Subperiosteal facelift
45.1
7.7
9
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
45.1
7.7
9
*
N06AX21
ATC
duloxetine; oral
1.6
7.7
193
1240
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.7
438
3344
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
5.6
7.7
21
38
2377A
ICD-9 Finland
Neoplasm of uncertain behaviour of endocrine glands and nervous system, Neurofibromatosis
18.4
7.6
11
6
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
18.4
7.6
11
6
N01
ICPC
Headache
1.6
7.6
176
1108
H02
ICPC
Hearing complaint
1.6
7.6
219
1459
C71.69
ICD-10 Finland
Malignant tumor of the cerebellum other or unspecified histology
80.3
7.4
8
*
3314A
ICD-9 Finland
Other cerebral degenerations, Obstructive hydrocephalus
80.3
7.4
8
*
N06AX16
ATC
venlafaxine; oral
1.5
7.4
243
1669
R11
ICD-10 Finland
Nausea and vomiting
1.7
7.4
141
841
J01DB01
ATC
cefalexin; oral
1.3
7.3
1661
15375
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
1.8
7.3
118
668
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
7.3
7
*
3259
FHL
Other measure in this category
+∞
7.3
7
*
9361/1-C75.3
ICD-O-3
Pineocytoma of pineal gland
+∞
7.3
7
*
2311
FHL
Resection
+∞
7.3
7
*
Q85.9
ICD-10 Finland
Phakomatosis, unspecified
+∞
7.3
7
*
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
7.3
74
351
102
Kela drug reimbursment
Diabetes insipidus
9.4
7.3
14
15
Z97.4
ICD-10 Finland
Presence of external hearing-aid
2.0
7.3
85
426
A28
ICPC
Limited function/disability NOS
1.5
7.3
268
1884
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.2
7.2
73
343
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
15.8
7.2
11
7
T88.9
ICD-10 Finland
Complication of surgical and medical care, unspecified
5.8
7.2
19
33
D32
ICD-10 Finland
Benign neoplasm of meninges
30.1
7.1
9
*
M03BX02
ATC
tizanidine; oral
1.3
7.1
1182
10483
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
20.1
7.1
10
5
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
6.6
7.1
17
26
ZXA00
NOMESCO Finland
Right side
1.3
7.1
498
3932
K07.60
ICD-10 Finland
Snapping jaw
2.0
7.0
86
441
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.2
7.0
68
317
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.0
699
5804
CBF99
NOMESCO Finland
Other operation for ectropion
10.0
7.0
13
13
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
10.0
7.0
13
13
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
6.9
762
6411
D18.0
ICD-10 Finland
Haemangioma, any site
2.6
6.9
48
188
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
6.9
421
3248
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.4
6.9
343
2559
H90.5
ICD-10 Finland
Sensorineural hearing loss, unspecified
3.8
6.9
27
72
G40
ICD-10 Finland
Epilepsy
3.8
6.9
27
72
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
2.2
6.8
66
307
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
6.8
363
2737
H02.1
ICD-10 Finland
Ectropion of eyelid
4.2
6.8
24
58
G82.2
ICD-10 Finland
Paraplegia, unspecified
6.1
6.8
17
28
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
40.2
6.8
8
*
CBK10
NOMESCO Finland
Operation for lagophtalmus
40.2
6.8
8
*
74340
ICD-8 Finland
Other congenital anomalies of nervous system, Neurofibromatosis
40.2
6.8
8
*
AAA00
NOMESCO Finland
Exploratory craniotomy
40.2
6.8
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.6
6.7
189
1250
G97.8
ICD-10 Finland
Other postprocedural disorders of nervous system
22.6
6.7
9
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
22.6
6.7
9
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
6.6
124
733
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.4
6.6
53
224
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
6.6
204
1381
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.6
538
4335
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.9
6.6
38
133
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
12.3
6.6
11
9
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
6.6
336
2514
H02AB06
ATC
prednisolone; systemic
1.3
6.5
860
7389
R53
ICD-10 Finland
Malaise and fatigue
1.4
6.5
349
2635
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
1.8
6.4
110
634
2139
FHL
Other measure in this category
70.0
6.4
7
*
G03.8
ICD-10 Finland
Meningitis due to other specified causes
70.0
6.4
7
*
C71.09
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles other or unspecified histology
70.0
6.4
7
*
D16.6
ICD-10 Finland
Benign neoplasm: Vertebral column
70.0
6.4
7
*
Z98.2
ICD-10 Finland
Presence of cerebrospinal fluid drainage device
70.0
6.4
7
*
-
ICD-10 Finland
NA
2.4
6.4
50
211
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.6
6.4
170
1108
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
2.1
6.4
66
318
G81.1
ICD-10 Finland
Spastic hemiplegia
14.3
6.4
10
7
UKC02
NOMESCO Finland
Cystoscopy
1.4
6.4
277
2012
RS221
NOMESCO Finland
NA
3.0
6.3
34
116
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
6.3
118
702
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
6.0
6.3
16
27
G50.8
ICD-10 Finland
Other disorders of trigeminal nerve
11.0
6.3
11
10
G82.1
ICD-10 Finland
Spastic paraplegia
18.1
6.3
9
5
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
6.3
6
*
3253
FHL
Tarsoraphy
+∞
6.3
6
*
G97.2
ICD-10 Finland
Intracranial hypotension following ventricular shunting
+∞
6.3
6
*
C71.51
ICD-10 Finland
Malignant tumor of cerebral ventricle ependymoma
+∞
6.3
6
*
9421/1-C72.0
ICD-O-3
Pilocytic astrocytoma of spinal cord
+∞
6.3
6
*
9560/0-C71.9
ICD-O-3
Schwannoma, NOS, of brain, NOS
+∞
6.3
6
*
D43.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cranial nerves
26.7
6.2
8
*
9537/0-C70.0
ICD-O-3
Transitional meningioma of cerebral meninges
26.7
6.2
8
*
H01AC01
ATC
somatropin; parenteral
7.0
6.2
14
20
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
3.4
6.2
27
79
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
2.6
6.2
41
158
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.5
6.2
44
176
G41.9
ICD-10 Finland
Status epilepticus, unspecified
6.3
6.2
15
24
NA1DG
NOMESCO Finland
Cervical spine very extensive MRI examination with high intensity magnet
7.7
6.1
13
17
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
6.1
279
2043
Z00.0
ICD-10 Finland
General medical examination
1.4
6.0
335
2543
M79.6
ICD-10 Finland
Pain in limb
1.3
6.0
636
5298
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
6.7
6.0
14
21
H16.8
ICD-10 Finland
Other keratitis
10.0
6.0
11
11
R1260
NOMESCO Finland
Evaluation of communicative skills
2.6
6.0
40
155
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.8
6.0
88
485
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
188
129
15.69
212.75
1.6
1.9
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
521
2351
2.54
70.16
7.0
7.8
mmol/l
1.2
1.1
0.17
393
1850
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
518
2359
2.51
68.23
7.1
7.8
kpa
5.1
5.1
0.11
498
2253
(3027801) Oxygen [Partial pressure] in Arterial blood
518
2360
2.51
68.16
7.1
7.8
kpa
16.2
12.3
26.00
496
2255
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
309
1098
3.07
65.55
7.2
10.0
mmol/l
24.3
24.4
0.24
298
1033
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
112
193
6.03
62.47
2.4
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1338
9240
1.97
58.64
6.9
6.2
mmol/l
1.2
1.2
1.06
1258
8354
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
78
97
8.27
58.63
2.0
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1422
10156
1.94
54.98
7.5
6.9
mmol/l
1.2
1.2
0.35
1280
8558
(3044290) Cell count panel - Cerebral spinal fluid
158
428
3.87
51.06
2.0
1.5
—
—
—
0
0
(4035726)
387
1760
2.42
49.90
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
998
6502
1.90
49.43
2.3
2.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1587
12014
1.89
48.49
5.7
4.8
mmol/l
6.5
6.7
3.47
1523
11226
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
160
459
3.66
47.55
2.0
1.6
e6/l
1186.2
1426.7
0.10
127
368
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
160
459
3.66
47.55
1.9
1.5
e6/l
44.9
31.5
0.22
123
351
(3033658) Prothrombin time (PT) actual/Normal
836
5206
1.91
47.03
3.7
4.0
%
92.8
90.0
2.74
817
5075
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
171
520
3.46
46.50
1.8
1.4
mg/l
644.4
531.7
1.32
164
489
(3016018) Differential panel - Cerebral spinal fluid
100
217
4.76
43.14
2.1
1.7
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
299
1290
2.50
42.91
7.2
8.1
mmol/l
24.3
24.9
2.40
299
1284
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
777
5038
1.79
36.49
2.2
2.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
56
93
6.14
32.39
2.6
2.2
umol/l
51.6
50.6
0.08
50
69
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
139
464
3.11
32.38
1.7
1.4
mmol/l
3.6
3.8
1.96
128
436
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1268
9661
1.64
31.28
3.9
4.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
884
6158
1.68
30.95
2.4
2.2
u/l
205.8
224.3
0.22
851
5782
(3014007) Fractional oxyhemoglobin in Arterial blood
276
1321
2.23
30.85
8.9
9.6
%
94.9
94.0
1.50
276
1314
(40768804) Tissue Pathology biopsy report
1105
8225
1.62
29.28
2.4
2.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
359
1946
1.99
28.78
8.7
8.7
g/l
124.5
121.2
2.54
353
1871
(3016502) Oxygen saturation in Arterial blood
381
2109
1.95
28.74
8.4
8.2
%
96.8
95.7
3.15
374
2034
(3023410) Appearance of Cerebral spinal fluid
81
214
3.88
27.09
2.0
1.9
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
66
151
4.46
26.71
2.1
1.2
mmol/l
2.7
2.0
1.57
61
142
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
42
75
5.68
22.58
2.7
2.9
umol/l
28.9
29.9
0.22
34
52
(3032080) INR in Blood by Coagulation assay
1061
8173
1.52
22.12
6.1
9.5
inr
1.2
1.3
3.44
261
2373
(3019550) Sodium [Moles/volume] in Serum or Plasma
2285
21049
2.09
21.88
20.3
16.4
mmol/l
139.7
139.7
0.43
2259
20504
(3023103) Potassium [Moles/volume] in Serum or Plasma
2286
21103
2.07
21.10
20.2
16.5
mmol/l
3.9
4.0
4.14
2257
20521
(3036481) Cortisol [Moles/volume] in Serum or Plasma
324
1919
1.79
19.32
3.1
2.2
nmol/l
336.5
368.4
2.27
301
1756
(3014576) Chloride [Moles/volume] in Serum or Plasma
407
2576
1.69
19.17
7.7
7.3
mmol/l
104.7
104.3
0.79
398
2521
(3018677) aPTT in Platelet poor plasma by Coagulation assay
468
3149
1.60
17.15
2.0
2.2
s
29.1
29.8
1.77
460
3053
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2217
20486
1.78
17.13
17.1
14.2
mg/l
23.5
24.0
0.26
1848
16171
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1282
10637
1.43
16.37
6.3
6.2
umol/l
10.9
11.7
1.57
1225
10073
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
27
43
6.34
16.29
1.2
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
801
6104
1.46
16.24
3.3
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1086
8785
1.42
15.79
4.7
4.9
g/l
35.7
35.5
0.66
1011
8167
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
75
270
2.83
15.37
2.1
1.2
nmol/l
0.1
0.4
—
8
17
(3013650) Neutrophils [#/volume] in Blood by Automated count
1402
11937
1.40
14.76
9.0
9.0
e9/l
4.2
4.1
0.52
1203
10403
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
235
1369
1.79
14.69
2.6
2.4
au/ml
24.6
23.0
0.08
15
67
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
379
2513
1.60
14.58
7.1
6.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
131
627
2.15
14.53
5.2
4.2
mmol/l
3.8
3.9
2.24
122
589
(3000991) Gas panel - Venous blood
287
1781
1.69
14.34
8.4
8.7
—
—
—
0
0
(3020891) Body temperature
158
818
1.99
14.20
6.2
4.8
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
291
1824
1.67
13.99
8.0
7.4
mmol/l
1.3
1.3
0.62
281
1760
(3018418) pH of Serum or Plasma
775
6013
1.42
13.76
4.2
4.0
ph
7.4
7.4
0.22
116
1148
(3008152) Bicarbonate [Moles/volume] in Arterial blood
218
1267
1.79
13.73
9.2
7.4
mmol/l
25.3
24.6
2.58
209
1179
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
68
248
2.79
13.63
2.2
1.2
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
66
237
2.83
13.62
2.0
1.2
nmol/l
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
73
277
2.68
13.57
5.2
7.0
mg/l
9.9
11.8
2.96
64
258
(3001604) Monocytes [#/volume] in Blood
1220
10237
1.38
13.51
6.2
5.8
e9/l
0.6
0.6
0.29
1025
8832
(3019060) Gas panel - Arterial blood
230
1365
1.76
13.48
6.4
5.1
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
213
1239
1.79
13.37
1.4
1.3
au/ml
38.8
46.8
0.27
12
59
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1768
15787
1.42
13.35
8.0
7.5
u/l
76.6
78.7
1.25
1686
14847
(3006315) Basophils [#/volume] in Blood
1222
10280
1.37
13.20
6.2
5.8
e9/l
0.0
0.0
0.38
1025
8877
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1758
15735
1.40
12.69
4.6
4.0
pmol/l
14.8
14.8
0.37
1609
14296
(3013115) Eosinophils [#/volume] in Blood
1254
10640
1.36
12.59
6.4
6.1
e9/l
0.2
0.2
0.47
1067
9322
(3019198) Lymphocytes [#/volume] in Blood
1243
10535
1.36
12.56
6.3
5.9
e9/l
1.9
1.9
1.45
1057
9273
(3037467) Urinalysis macro (dipstick) panel - Urine
1590
14068
1.36
11.82
5.0
4.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1527
13438
1.36
11.68
5.5
4.5
e6/l
606.1
1763.6
1.17
22
186
(3021387) Prolactin [Units/volume] in Serum or Plasma
130
674
1.98
11.67
2.3
1.6
mu/l
427.2
308.1
1.36
125
610
(3012095) Magnesium [Moles/volume] in Serum or Plasma
463
3359
1.47
11.53
3.2
3.4
mmol/l
0.8
0.8
0.75
434
3145
(3013707) Erythrocyte sedimentation rate by Westergren method
1690
15125
1.37
11.50
4.4
4.1
mm/h
11.1
12.2
2.67
1571
13977
(3009214) Lutropin [Units/volume] in Serum or Plasma
108
542
2.04
10.64
2.0
1.4
u/l
7.6
9.6
0.92
82
436
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1017
8506
1.33
10.57
2.4
2.3
nmol/l
77.3
76.9
0.18
918
7629
(3020779) Urea [Moles/volume] in Serum or Plasma
277
1855
1.56
10.06
5.3
7.6
mmol/l
8.5
9.6
1.46
263
1767
(3011985) Renin [Units/volume] in Plasma
61
247
2.51
10.03
1.6
1.4
mu/l
39.2
48.2
0.32
51
215
(42870588) Differential panel, method unspecified - Blood
849
6991
1.33
9.58
6.5
5.9
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
1094
9339
1.31
9.49
6.3
6.0
%
0.7
0.7
0.38
1020
8715
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2018
18786
1.40
9.39
5.3
4.8
mu/l
1.9
2.1
1.36
1852
17183
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
28
75
3.76
9.33
1.2
1.1
ng/l
75.6
540.6
—
8
20
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2052
19177
1.41
9.16
15.3
13.1
ml/min/173m2
83.2
81.1
4.05
1754
15788
(3035637) Corticotropin [Mass/volume] in Plasma
60
254
2.40
9.01
1.7
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
179
1108
1.66
9.00
10.8
10.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
462
3494
1.40
8.95
2.9
2.7
e6/l
1.0
1.3
0.79
269
1974
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
49
190
2.61
8.84
1.1
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
56
232
2.45
8.82
1.3
1.4
pmol/l
265.4
292.4
0.23
45
175
(3019069) Monocytes/100 leukocytes in Blood
1121
9663
1.29
8.80
6.7
6.3
%
8.8
8.6
0.72
1048
9039
(3006504) Eosinophils/100 leukocytes in Blood
1115
9616
1.29
8.68
6.4
6.0
%
2.8
2.8
0.16
1038
8955
(40758558) Short blood count panel - Blood
654
5248
1.33
8.66
6.2
6.6
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
915
7704
1.30
8.53
3.6
3.6
ng/l
35.3
51.7
0.86
634
5256
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
39
138
2.86
8.38
1.1
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
489
3772
1.37
8.35
3.0
3.0
mmol/l
2.4
2.5
1.21
420
3313
(3030467) Casts [#/volume] in Urine by Automated count
693
5637
1.32
8.28
3.6
3.1
e6/l
0.4
0.4
0.03
545
4232
(3018095) Leukocytes [#/volume] in Urine
862
7228
1.30
8.21
4.1
3.7
e6/l
70.5
103.5
0.38
640
5084
(3018010) Neutrophils/100 leukocytes in Blood
1127
9787
1.28
8.11
6.2
5.9
%
57.2
57.0
0.19
1058
9153
(3002030) Lymphocytes/100 leukocytes in Blood
1141
9926
1.28
8.09
6.5
6.1
%
27.8
28.1
0.49
1065
9255
(3015377) Calcium [Moles/volume] in Serum or Plasma
833
6965
1.30
8.08
3.4
3.3
mmol/l
2.4
2.4
0.18
710
6094
(3000850) Epithelial cells [#/volume] in Urine
544
4287
1.34
8.06
2.8
2.6
e6/l
4.4
5.9
2.76
482
3755
(43055514) Macroprolactin [Presence] in Serum or Plasma
18
39
4.64
7.87
1.5
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
677
5524
1.31
7.84
3.5
3.1
—
—
—
0
0
(3026782) Osmolality of Urine
507
3969
1.35
7.83
2.9
2.8
mosm/kgh2o
547.5
550.0
0.08
430
3373
(3003458) Phosphate [Moles/volume] in Serum or Plasma
371
2765
1.40
7.77
5.2
5.9
mmol/l
1.0
1.0
0.89
342
2561
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
123
2.87
7.64
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
742
6150
1.29
7.60
3.6
3.2
e6/l
35.9
86.1
2.26
591
4713
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
38
141
2.72
7.51
1.1
1.1
mg/l
302.2
272.3
0.32
32
120
(40761535) Cells panel - Urine sediment
247
1719
1.49
7.47
3.7
3.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
327
2402
1.42
7.43
1.7
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
586
4724
1.31
7.34
4.2
3.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
2230
21330
1.45
7.15
15.8
13.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
118
2.82
7.01
1.1
1.1
u/l
1.0
1.2
1.69
16
64
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
32
114
2.83
6.84
1.2
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
10
14
7.17
6.70
1.0
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
579
4715
1.30
6.65
1.6
1.5
nmol/l
20.6
20.7
0.02
494
4001
(3023368) Bacteria identified in Blood by Culture
668
5551
1.28
6.53
4.4
4.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
955
8304
1.24
6.28
2.1
2.0
pmol/l
95.3
95.4
0.01
512
4294
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
426
3352
1.33
6.25
1.8
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2263
21792
1.44
6.12
11.7
10.4
u/l
26.1
26.2
0.12
2207
21019
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
748
6368
1.25
5.85
2.8
2.6
u/l
57.5
57.0
0.07
688
5875
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
412
3259
1.32
5.80
3.1
2.9
e6/l
2.4
2.5
0.12
224
1750
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
178
1235
1.48
5.50
1.7
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
131
853
1.57
5.45
1.9
1.9
u/l
38.1
39.0
0.21
115
754
(3019225) pH of Specimen
272
2045
1.37
5.37
4.2
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
1554
14370
1.22
5.22
3.8
3.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1129
10137
1.21
5.09
4.4
3.6
estimate
0.0
0.0
0.80
190
1850
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
44
211
2.10
5.06
2.2
1.5
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
60
3.18
5.04
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
19
5.28
5.04
1.4
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
23
4.80
5.01
1.7
3.7
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
61
3.13
4.91
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2340
22780
1.49
4.90
25.5
20.8
e9/l
252.2
251.0
0.40
2300
22190
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
32
137
2.35
4.83
1.0
1.2
—
—
—
0
0
(4027681)
28
113
2.49
4.79
1.2
1.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
128
855
1.52
4.79
1.8
1.4
iu/l
29.4
29.1
0.04
110
715
(3019150) Specific gravity of Urine by Refractometry
526
4390
1.25
4.78
4.8
4.0
kg/l
1.0
1.0
0.04
75
615
(3024731) MCV [Entitic volume]
2340
22791
1.48
4.77
25.5
20.8
fl
90.6
91.0
4.64
2323
22456
(3035350) Ketones [Presence] in Urine by Test strip
1111
10005
1.20
4.74
4.3
3.6
estimate
0.0
0.0
0.00
186
1880
(3026361) Erythrocytes [#/volume] in Blood
2340
22795
1.47
4.72
25.5
20.8
e12/l
4.5
4.5
0.07
2300
22141
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1459
13480
1.20
4.67
3.7
3.1
u/l
49.2
48.7
0.09
1384
12552
(3000963) Hemoglobin [Mass/volume] in Blood
2340
22801
1.47
4.65
25.7
21.0
g/l
134.6
135.3
1.59
2327
22467
(3035941) MCH [Entitic mass]
2339
22792
1.46
4.61
25.4
20.7
pg
30.2
30.3
2.90
2321
22455
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
22
80
2.77
4.61
1.2
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
2339
22798
1.46
4.54
25.6
20.9
e9/l
6.8
6.7
0.35
2300
22146
(3021601) Nitrite [Presence] in Urine by Test strip
1112
10043
1.19
4.52
5.7
4.9
estimate
0.0
0.0
0.50
191
1920
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
763
6659
1.21
4.49
3.6
3.2
u/l
34.0
33.9
0.02
725
6331
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
220
1649
1.37
4.45
2.6
2.6
ml/min/173m2
72.3
66.4
0.35
78
660
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
65
2.94
4.44
1.1
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
30
131
2.31
4.36
1.2
1.1
nmol/l
0.1
3.5
—
6
25
(3052851) Hemolysis interference index of Serum or Plasma
96
615
1.58
4.35
2.7
3.3
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
66
2.89
4.33
1.1
1.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
356
2875
1.28
4.25
1.2
1.2
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1834
17382
1.21
4.20
22.0
18.2
g/l
332.7
332.5
0.66
1824
17247
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1399
12943
1.19
4.19
2.9
3.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
73
2.75
4.18
1.4
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
27
4.09
4.16
1.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1012
9121
1.19
4.08
10.0
9.4
e9/l
0.0
0.0
0.86
781
7452
(3019309) Folate [Moles/volume] in Red Blood Cells
450
3764
1.24
3.96
1.8
1.7
nmol/l
1170.4
1186.6
0.11
344
2850
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
312
2502
1.28
3.94
4.9
4.5
%
32.2
32.4
0.12
219
1689
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
12
33
3.65
3.92
1.7
1.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
603
5214
1.21
3.82
2.3
2.2
mg/l
3.0
3.0
0.05
504
4427
(3017446) Testosterone [Moles/volume] in Serum or Plasma
194
1462
1.35
3.82
2.7
2.2
nmol/l
12.1
12.8
0.52
170
1290
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
46
250
1.86
3.80
1.1
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
6
5
12.02
3.76
1.0
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
113
777
1.48
3.74
1.6
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
438
3678
1.23
3.71
3.1
3.0
ug/l
0.8
0.8
0.20
299
2424
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
313
1.74
3.63
5.7
5.2
umol/l
372.8
365.9
0.14
48
271
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
584
5058
1.20
3.62
4.6
4.3
%
21.7
21.5
0.16
311
2448
(1761868) Lipid panel - Serum or Plasma
628
7143
0.84
3.56
2.8
2.8
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
9
7.80
3.56
1.1
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
181
1366
1.35
3.55
3.4
3.9
kpa
5.1
5.2
0.45
161
1268
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
24
105
2.30
3.52
3.0
1.2
%
72.0
68.4
—
5
13
(3037522) Nuclear Ab [Titer] in Serum
329
2693
1.26
3.51
1.3
1.3
titre
542.8
513.8
0.11
65
554
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
283
2278
1.27
3.48
4.1
4.4
u/l
240.2
251.4
0.56
265
2152
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
288
1.75
3.45
1.7
1.5
nmol/l
0.3
0.3
0.69
40
222
(3001122) Ferritin [Mass/volume] in Serum or Plasma
972
8831
1.17
3.37
2.8
2.8
ug/l
118.3
126.7
0.46
889
8156
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
10
27
3.71
3.35
1.2
1.3
—
—
—
0
0
(4268621)
38
204
1.88
3.30
2.5
2.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
137
1002
1.39
3.28
3.5
4.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
129
934
1.40
3.28
1.9
1.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
119
852
1.42
3.23
1.6
1.9
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
16
60
2.68
3.22
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
23
103
2.24
3.22
1.1
1.2
—
—
—
0
0
(3013512) EKG study
665
5880
1.18
3.22
4.3
3.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
92
628
1.48
3.21
8.0
6.9
mmol/l
1.2
1.3
0.21
81
546
(3002256) Pathology report gross observation
314
2584
1.25
3.20
1.3
1.3
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
11
33
3.34
3.19
1.1
1.1
—
—
—
0
0
(3039000) Anion gap in Blood
70
451
1.57
3.18
8.8
8.0
mmol/l
10.3
11.3
1.76
65
400
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
165
1250
1.34
3.18
3.1
3.3
pmol/l
4.4
4.5
0.40
150
1099
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
286
2331
1.26
3.18
1.8
1.7
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
42
236
1.79
3.18
1.9
1.4
mosm/kgh2o
283.3
279.6
0.56
32
176
(3018572) Chloride [Moles/volume] in Blood
70
452
1.56
3.15
8.8
8.0
mmol/l
106.3
105.3
0.92
65
401
(3003694) ABO and Rh group [Type] in Blood
642
5674
1.18
3.11
1.4
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
286
2338
1.25
3.10
1.9
1.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
347
2899
1.23
3.08
2.2
2.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
10
29
3.46
3.04
1.2
1.2
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
169
1296
1.33
3.01
3.3
3.9
mmol/l
1.3
1.8
1.31
122
976
(3009343) pH of Capillary blood
175
1350
1.32
3.00
3.4
3.9
ph
7.4
7.4
0.45
17
166
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
18
75
2.41
2.97
1.1
1.0
—
—
—
0
0
(4024509)
35
191
1.84
2.93
1.7
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
17
4.72
2.92
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
613
5424
1.17
2.91
5.1
4.0
estimate
0.0
0.0
1.28
188
1848
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
10
30
3.34
2.90
2.6
3.5
umol/l
46.0
45.9
—
10
23
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
113
820
1.40
2.87
6.6
5.7
%
1.6
1.6
0.01
106
762
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
700
6279
1.16
2.77
5.3
4.9
ug/l
3.2
2.7
0.40
627
5623
(3007930) Methemoglobin/Hemoglobin.total in Blood
112
819
1.38
2.74
6.6
5.7
%
0.9
0.9
1.12
105
764
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
188
1486
1.29
2.71
1.6
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
84
587
1.45
2.65
1.7
1.7
—
—
—
0
0
(3036489) Thrombin time
108
793
1.38
2.59
2.2
2.2
s
21.4
21.7
0.18
94
703
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
222
1.72
2.58
1.1
1.2
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
11
5.46
2.54
1.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
399
3445
1.19
2.52
1.3
1.3
iu/ml
37.5
34.1
0.17
116
1076
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2034
19713
1.18
2.51
4.9
4.5
mmol/l
5.8
5.9
5.32
1856
17944
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
84
595
1.43
2.49
2.0
2.2
u/l
9277.3
4348.7
0.56
19
241
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
8
21
3.82
2.46
1.5
1.1
nmol/l
2.6
5.6
—
8
21
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
116
870
1.35
2.45
3.4
4.2
mmol/l
24.9
24.8
0.21
105
816
(3000494) Fungus identified in Specimen by Culture
286
2403
1.21
2.43
1.6
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
75
524
1.44
2.40
1.9
2.1
mg/l
10.8
11.7
0.51
69
484
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
86
617
1.41
2.39
1.5
1.5
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
8
22
3.64
2.36
1.0
1.1
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
25
133
1.89
2.31
1.1
1.0
ng/l
563.1
676.9
1.01
15
82
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
25
133
1.89
2.31
1.1
1.0
ng/l
312.7
309.5
0.02
13
85
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
10
35
2.86
2.30
1.1
1.0
—
—
—
0
0
(4034850)
89
648
1.39
2.28
9.4
9.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
23
3.49
2.27
1.1
1.2
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
25
135
1.86
2.22
1.1
1.0
ng/l
44.1
47.0
0.13
13
82
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
135
1052
1.30
2.22
2.6
2.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
104
781
1.35
2.21
2.5
2.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
13
54
2.41
2.19
1.2
1.1
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
233
1941
1.22
2.17
3.8
4.0
kpa
5.8
5.9
0.06
228
1881
(3022217) INR in Platelet poor plasma by Coagulation assay
301
2570
1.19
2.17
21.4
25.0
inr
1.4
1.3
0.47
35
362
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
7
19
3.69
2.15
1.0
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
7
19
3.69
2.15
1.0
1.1
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
19
3.69
2.15
1.1
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
267
2259
1.20
2.13
1.4
1.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
47
307
1.54
2.11
1.3
1.2
u/ml
3.0
5.6
1.07
25
132
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
835
7701
1.13
2.10
4.7
3.8
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
37
2.71
2.10
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
8
25
3.21
2.09
1.1
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
443
3920
1.16
2.08
3.9
3.7
ng/l
144.5
413.4
3.86
345
3032
(3006462) Nitrate [Presence] in Urine
17
82
2.08
2.06
6.0
2.9
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
192
1579
1.23
2.04
4.1
3.9
ng/l
85.3
87.9
0.16
170
1371
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
62
433
1.44
2.03
1.1
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
24
132
1.83
2.03
1.1
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
83
613
1.37
1.99
1.2
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
230
1933
1.21
1.98
3.9
4.0
mmol/l
2.1
1.9
0.24
199
1555
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
121
946
1.29
1.97
3.5
3.0
%
0.7
0.6
0.73
115
912
(3050794) Legionella sp Ab [Presence] in Serum
7
21
3.34
1.96
1.0
1.0
—
—
—
0
0
(4211845)
18
91
1.99
1.95
6.2
2.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
89
668
1.34
1.93
2.8
2.6
g/l
1.4
1.0
0.31
72
588
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
27
2.97
1.93
1.1
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
185
1531
1.23
1.87
3.2
2.8
g/l
10.2
10.5
0.34
169
1392
(42529406) Shigella sp [Presence] in Stool by Culture
83
620
1.35
1.87
1.2
1.2
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
268
2298
1.19
1.87
2.3
2.7
%
1.8
1.8
0.29
232
2039
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
53
366
1.46
1.87
3.7
3.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
81
603
1.35
1.87
1.2
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
47
317
1.49
1.86
1.3
1.2
u/ml
3.8
4.0
0.03
19
108
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
209
1754
1.21
1.84
2.6
2.4
ug/l
5.6
7.0
0.99
183
1557
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
315
2742
1.17
1.84
2.6
2.6
%
22.3
22.8
0.25
273
2361
(3010838) Calcium [Moles/time] in 24 hour Urine
20
108
1.86
1.81
1.5
1.7
—
9.6
—
0
8
(3028433) Virus identified in Specimen by Culture
15
73
2.06
1.80
1.2
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
109
853
1.29
1.79
2.3
1.4
u/ml
40.6
18.2
—
5
21
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
8
29
2.76
1.79
1.0
1.5
nmol/l
4.8
359095.6
—
8
22
(3003181) Sodium [Moles/volume] in Urine
53
370
1.44
1.78
1.8
1.5
mmol/l
73.9
62.0
0.95
46
296
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
80
600
1.34
1.77
2.7
2.7
%
171.8
184.8
0.79
74
573
(3045424) Erythrocytes [Presence] in Urine
52
362
1.45
1.77
1.7
1.6
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1926
18721
1.13
1.76
5.9
5.7
mmol/mol
38.8
39.8
5.49
1778
17324
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
78
584
1.35
1.75
1.4
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
204
1719
1.20
1.74
2.7
2.7
e9/l
66.9
70.5
0.90
153
1296
(3002385) Erythrocyte distribution width [Ratio]
1766
17087
1.12
1.73
20.3
17.2
%
13.7
13.7
0.12
1739
16693
(3025941) Bacteria identified in Stool by Culture
141
1146
1.24
1.71
1.3
1.2
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
74
552
1.35
1.71
1.3
1.2
u/ml
17.9
35.4
—
7
28
(3020191) Ethanol [Moles/volume] in Serum or Plasma
25
150
1.67
1.63
1.3
1.4
promille
1.5
1.1
0.47
18
117
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
5
14
3.58
1.61
1.6
1.4
%
10.4
16.8
—
5
9
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
147
1209
1.23
1.61
1.5
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
629
5788
1.12
1.60
2.9
3.0
ng/l
1047.5
1356.9
1.43
532
4947
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
8
32
2.50
1.59
1.0
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
35
231
1.52
1.57
3.2
4.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
357
3180
1.14
1.55
2.4
2.5
umol/l
13.0
13.1
0.04
325
2943
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
29
184
1.58
1.54
1.2
1.2
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
5
15
3.34
1.52
2.0
1.3
%
35.6
43.3
—
5
9
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
55
401
1.38
1.49
1.6
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
280
2459
1.16
1.49
2.1
2.3
ug/g
140.8
136.0
0.07
216
1938
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
72
549
1.32
1.47
1.3
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
65
489
1.34
1.46
1.3
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
9
38
2.37
1.45
1.6
2.2
umol/l
23.9
17.5
—
9
38
(3023183) Ammonium ion [Moles/volume] in Plasma
60
448
1.35
1.42
2.5
3.1
umol/l
32.9
35.6
0.41
52
385
(3021879) Hepatitis B virus core Ab [Presence] in Serum
172
1458
1.19
1.42
1.4
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
331
2953
1.14
1.41
2.4
2.5
g/l
2.3
2.3
0.00
300
2737
(3043238) Trisomy 21 risk [Likelihood] in Fetus
21
338
0.62
1.40
1.4
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
9
40
2.25
1.40
2.0
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
75
582
1.30
1.37
1.7
1.6
g/l
0.2
0.2
0.98
70
550
(3014051) Protein [Presence] in Urine by Test strip
63
477
1.33
1.37
2.0
2.1
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
23
2.61
1.36
1.5
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
258
2269
1.15
1.36
1.7
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
15
82
1.83
1.35
1.0
1.1
miu/ml
1159.8
1625.4
0.73
15
82
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
31
207
1.50
1.35
3.2
2.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
79
619
1.29
1.35
2.1
2.4
g/l
39.0
37.8
0.93
64
535
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
221
1924
1.16
1.34
2.6
2.4
u/l
31.0
63.9
0.73
184
1651
(3017732) Neutrophils [#/volume] in Blood
164
1393
1.19
1.33
3.9
3.1
e9/l
4.1
4.0
0.02
119
1099
(3033923) Metanephrine [Moles/time] in 24 hour Urine
10
47
2.13
1.33
1.0
1.1
umol/24h
0.7
0.7
—
5
29
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
36
249
1.45
1.33
1.1
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
155
1311
1.19
1.32
3.2
2.9
—
—
—
0
0
(4306422)
42
300
1.41
1.31
1.2
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
83
1.81
1.31
1.1
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
21
331
0.63
1.30
1.4
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
93
748
1.25
1.30
1.2
1.2
u/ml
0.3
0.8
1.10
12
67
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
96
1181
0.81
1.29
1.5
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
57
748
0.76
1.29
1.4
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
18
2.78
1.28
2.0
1.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
18
2.78
1.28
2.0
5.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
105
858
1.23
1.28
1.2
1.2
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
37
260
1.43
1.27
1.3
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
28
186
1.51
1.26
1.1
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
36
252
1.43
1.26
1.1
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
21
328
0.64
1.26
1.4
1.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
234
2058
1.15
1.25
3.7
4.2
ug/l
9.1
19.9
1.07
190
1680
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
30
203
1.48
1.24
1.3
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
123
1025
1.21
1.24
3.9
4.6
mmol/l
24.5
24.1
0.82
113
930
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
36
253
1.43
1.24
1.1
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
78
619
1.27
1.23
1.6
1.6
iu/ml
0.1
10.9
0.50
17
111
(3004588) Protein electrophoresis panel - Serum or Plasma
160
1368
1.18
1.23
2.7
2.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
84
673
1.26
1.22
2.7
3.3
u/ml
0.4
0.4
0.04
46
387
(3015235) Bicarbonate [Moles/volume] in Capillary blood
68
531
1.29
1.22
3.2
3.2
mmol/l
24.2
25.1
1.07
56
463
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
33
229
1.45
1.22
1.6
1.7
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
24
156
1.54
1.20
1.1
1.3
mmol/l
11.8
12.1
—
8
48
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
38
2.11
1.18
1.0
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
12
64
1.88
1.18
1.2
1.0
%
79.3
91.0
—
6
35
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
57
1.93
1.17
1.5
2.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
11
57
1.93
1.17
1.5
2.8
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
31
215
1.45
1.16
2.5
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
69
545
1.27
1.14
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
250
1.41
1.12
1.1
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
250
1.41
1.12
1.1
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
11
196
0.56
1.12
1.3
1.4
mmol/l
4.7
6.5
1.28
11
182
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
30
2.34
1.12
1.1
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
58
1.90
1.12
1.4
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
150
1739
0.85
1.11
1.8
1.7
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
100
828
1.22
1.10
2.2
2.0
ug/l
2.2
1.7
0.34
85
738
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
209
1.44
1.10
1.7
1.7
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
492
4560
1.10
1.09
1.3
1.3
u/ml
1.8
1.4
0.26
134
1193
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
110
921
1.20
1.09
2.2
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
363
3314
1.11
1.09
1.3
1.2
u/ml
15.5
11.5
0.17
145
1293
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
472
4368
1.10
1.08
1.7
1.7
pmol/l
17571501.1
34825067.2
0.42
387
3621
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
252
1.39
1.08
1.1
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
722
1.23
1.07
2.1
2.5
g/l
10.2
10.3
0.05
69
621
(3014271) Vancomycin [Susceptibility]
16
97
1.65
1.06
4.6
2.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
68
543
1.26
1.05
1.4
1.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
153
1761
0.86
1.04
5.2
3.9
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
55
429
1.29
1.03
1.3
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
76
617
1.24
1.03
1.7
1.9
—
—
—
0
0
(1616796) Gas panel - Central venous blood
57
447
1.28
1.02
5.7
3.8
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
47
1.92
1.02
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
47
1.92
1.02
1.2
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
47
1.92
1.02
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
47
1.92
1.02
1.2
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
189
1667
1.14
1.01
2.9
2.7
g/l
66.3
66.5
0.15
165
1530
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
73
592
1.24
1.00
2.2
2.4
g/l
0.1
0.0
0.57
66
549
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
220
1962
1.13
1.00
2.3
2.2
g/l
0.2
0.2
0.18
205
1836
(3021901) Oxygen saturation in Capillary blood
49
379
1.30
0.98
3.0
2.9
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
56
441
1.28
0.98
2.4
2.3
g/l
131.6
129.7
0.22
37
329
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
41
309
1.33
0.98
1.2
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
23
2.18
0.98
2.0
1.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
387
3567
1.10
0.98
1.6
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
63
504
1.26
0.98
1.3
1.2
u/ml
62.8
3.3
—
5
52
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
64
513
1.25
0.97
1.3
1.2
u/ml
2.0
9.4
—
8
84
(3000330) Specific gravity of Urine by Test strip
118
1007
1.18
0.97
3.3
3.5
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
0
30
0.00
0.97
0.0
1.2
—
1118.1
—
0
22
(3007164) IgA [Mass/volume] in Serum or Plasma
433
4014
1.10
0.97
1.5
1.5
g/l
2.3
2.4
0.35
256
2427
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
10
54
1.86
0.96
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
88
732
1.21
0.96
2.1
2.5
g/l
3.0
3.1
0.80
65
582
(4062490)
26
182
1.43
0.96
1.2
1.4
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
121
1037
1.18
0.95
2.6
2.7
e6/l
0.3
0.3
0.16
116
1009
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
30
217
1.39
0.93
1.0
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
55
1.82
0.92
1.0
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
180
1595
1.14
0.92
1.2
1.2
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
30
407
0.73
0.91
1.3
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2080
20491
1.09
0.91
5.1
4.9
mmol/l
2.8
2.8
0.24
1921
18878
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
30
406
0.74
0.90
1.3
1.4
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
11
63
1.75
0.90
1.3
1.4
%
77.8
89.7
—
6
35
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
385
1.28
0.89
1.1
1.2
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
30
405
0.74
0.89
1.3
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
570
5367
1.08
0.89
2.6
2.7
umol/l
976.0
5704.1
6.56
499
4656
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
45
350
1.29
0.89
1.6
1.2
u/l
31.3
43.7
0.47
35
297
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
12
71
1.69
0.88
1.3
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
776
1.19
0.88
2.1
2.5
g/l
3.6
3.8
0.68
64
567
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
42
1.91
0.88
1.0
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
30
404
0.74
0.88
1.3
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
70
575
1.22
0.88
4.8
4.5
mg/l
1.4
1.5
0.50
63
533
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
66
539
1.23
0.88
1.3
1.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
777
1.19
0.87
2.1
2.5
g/l
7.1
7.4
0.65
66
595
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
92
777
1.19
0.87
2.1
2.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
63
770
0.81
0.87
1.6
1.7
mg/l
5.1
3.7
0.29
45
534
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
15
95
1.58
0.87
3.1
2.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
8
43
1.86
0.87
1.0
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1963
19302
1.08
0.87
4.1
3.9
mmol/l
1.3
1.3
0.80
1791
17668
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2030
19988
1.09
0.86
4.6
4.3
mmol/l
1.5
1.5
1.23
1877
18406
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
68
559
1.22
0.85
2.3
2.5
g/l
0.0
0.0
0.00
61
518
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
75
623
1.21
0.85
3.3
3.4
ratio
2.2
1.5
—
5
51
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
42
326
1.29
0.85
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
58
470
1.24
0.83
4.0
3.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
33
248
1.34
0.83
1.5
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
57
1.76
0.83
1.2
1.1
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
42
327
1.29
0.83
3.4
3.6
%
1.2
1.4
0.25
35
258
(3037121) Protein [Mass/volume] in Urine
88
745
1.19
0.83
2.4
3.6
g/l
0.3
0.3
0.12
40
307
(3004716) Salmonella sp identified in Stool by Organism specific culture
121
1052
1.16
0.82
1.2
1.3
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
46
1.74
0.82
1.4
1.3
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
34
258
1.32
0.81
1.2
1.3
mmol/l
6.6
7.4
1.36
22
186
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
11
177
0.62
0.81
1.1
1.4
u/l
877.7
348.0
0.64
11
172
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
400
1.26
0.81
1.2
1.2
u/ml
31.7
51.8
—
7
39
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
22
155
1.42
0.81
1.8
1.7
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
67
554
1.22
0.81
2.3
2.5
g/l
0.0
0.0
0.00
61
517
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
11
176
0.62
0.79
1.0
1.0
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
78
657
1.19
0.78
1.7
1.7
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
211
0.66
0.78
1.6
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2042
20133
1.08
0.78
4.6
4.4
mmol/l
4.7
4.7
0.56
1897
18661
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
82
1.59
0.78
1.1
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
131
1152
1.14
0.78
2.3
1.9
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
124
0.56
0.77
1.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
16
107
1.50
0.76
2.3
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
36
279
1.29
0.75
1.2
1.1
u/ml
7.0
2.5
0.55
16
122
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
22
158
1.40
0.74
1.2
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
480
4525
1.08
0.74
1.8
1.8
mg/l
1.2
1.2
0.00
357
3452
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
8
132
0.60
0.73
1.0
1.3
u/l
20.2
12.3
—
8
121
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
16
108
1.48
0.73
1.8
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
7
39
1.80
0.72
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
45
362
1.25
0.72
1.7
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
35
444
0.79
0.71
1.4
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
5
26
1.92
0.70
1.8
1.5
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
26
1.92
0.70
2.0
2.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
477
4505
1.07
0.70
4.9
4.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
28
212
1.32
0.70
2.1
3.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
58
1.55
0.69
1.3
1.9
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
143
0.63
0.69
1.2
1.2
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
75
639
1.18
0.69
3.4
3.4
mg/l
47.5
62.4
0.51
63
522
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
9
59
1.53
0.68
1.7
2.3
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
16
110
1.46
0.68
1.9
1.8
u/field
1.1
4.0
—
9
85
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
75
640
1.18
0.68
3.5
3.4
mg/l
35.2
79.1
1.15
63
524
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
20
144
1.39
0.68
1.5
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
20
144
1.39
0.68
3.2
2.4
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
26
196
1.33
0.67
1.2
1.2
u/l
97.1
57.4
0.62
15
141
(3017354) Segmented neutrophils/100 leukocytes in Blood
27
205
1.32
0.67
3.0
3.4
%
57.3
57.3
0.00
20
138
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
17
119
1.43
0.67
1.2
1.5
u/l
4.8
7.6
1.18
12
99
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
43
1.63
0.66
1.3
1.0
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
44
357
1.24
0.66
1.4
1.6
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
28
1.79
0.66
2.0
2.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
12
179
0.67
0.66
1.2
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
78
1.54
0.65
2.3
2.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
10
62
1.62
0.65
1.4
1.2
g/l
42.1
38.4
—
5
31
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
29
1.73
0.64
1.0
1.1
umol/24h
2.0
1.8
—
5
29
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
19
138
1.38
0.62
2.2
2.2
e6/l
609.8
720.8
—
9
58
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
288
1.25
0.62
1.7
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
16
113
1.42
0.61
1.9
1.5
ug/l
13.6
7.3
0.53
16
96
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
52
435
1.20
0.60
1.7
1.7
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
15.6
—
0
20
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
139
1.37
0.60
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
139
1.37
0.60
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
139
1.37
0.60
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
90
1024
0.87
0.60
1.7
1.7
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
17
122
1.40
0.60
1.1
1.1
ratio
1.1
1.1
—
7
51
(40765096) Chromosome analysis panel by Banding
11
72
1.53
0.59
1.4
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
19
140
1.36
0.58
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
19
140
1.36
0.58
1.1
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
24
184
1.31
0.57
2.4
2.3
e9/l
1.0
1.1
0.34
13
110
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
15
106
1.42
0.57
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
8
54
1.48
0.57
1.1
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
40
328
1.22
0.57
4.2
2.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
36
1.67
0.56
1.0
1.1
%
82.2
92.7
—
6
36
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
19
141
1.35
0.56
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
319
0.78
0.56
1.3
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
6
37
1.62
0.55
1.7
1.4
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
249
2320
1.08
0.55
2.7
2.8
umol/l
7.6
8.1
0.19
217
2023
(3009542) Hematocrit [Volume Fraction] of Blood
1903
18785
1.06
0.55
18.8
15.2
%
39.7
39.8
0.13
1368
13515
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
40
330
1.22
0.54
1.1
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
19
142
1.34
0.54
1.4
1.4
pmol/l
43.1
57.5
—
9
45
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
249
1.25
0.53
1.7
2.4
mg/l
31.0
27.0
—
9
64
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
18
238
0.75
0.53
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
133
1208
1.11
0.52
2.4
1.8
g/l
2.2
1.4
0.76
115
1101
(3000475) Leukocytes [#/volume] in Synovial fluid
56
480
1.17
0.52
1.4
1.7
e6/l
9088.9
14282.6
0.76
44
350
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
102
913
1.12
0.52
1.6
1.9
g/l
1.6
1.5
0.45
90
791
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
6
40
1.50
0.51
1.3
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
26
325
0.80
0.51
1.0
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
81
716
1.14
0.50
3.6
3.4
u/ml
114.9
5707.1
0.84
74
616
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
6
41
1.46
0.50
1.0
1.1
—
6.9
—
0
6
(3034426) Prothrombin time (PT)
10
67
1.49
0.49
1.4
1.3
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
189
1.27
0.49
1.7
1.4
%
25.1
31.0
0.54
18
115
(3025130) Human papilloma virus identified in Specimen
29
234
1.24
0.49
1.6
1.8
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
14
190
0.74
0.49
1.1
1.3
nmol/l
1.6
1.4
0.27
14
167
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
84
1.43
0.49
2.0
3.4
umol/l
389.8
130.8
—
5
51
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
7
110
0.64
0.48
1.1
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
148
1359
1.09
0.48
1.2
1.2
iu/ml
140.5
147.2
0.07
57
504
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
29
355
0.81
0.48
1.3
1.5
—
—
—
0
0
(4094501)
63
551
1.15
0.47
1.2
1.1
—
—
—
0
0
(4281824)
17
221
0.77
0.46
1.3
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
32
264
1.21
0.46
4.0
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
365
3475
1.06
0.46
1.9
1.8
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
120
0.67
0.45
1.3
1.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
37
439
0.84
0.45
3.6
4.0
mg/l
17.6
25.9
1.53
16
276
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
14
103
1.36
0.45
1.0
1.1
u/ml
—
14.6
—
0
9
(3010421) pH of Blood
63
553
1.14
0.45
7.7
4.2
ph
7.4
7.4
0.04
48
458
(21494755) Public health laboratory ask at order entry panel
168
1810
0.92
0.45
1.4
1.3
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
27
330
0.82
0.45
1.1
1.1
u/ml
0.3
2.7
—
7
84
(3044242) Glucose [Moles/volume] in Arterial blood
15
112
1.34
0.44
1.3
2.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
57
498
1.15
0.44
1.9
1.9
iu/l
3.2
4.8
1.11
19
169
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
18
230
0.78
0.43
2.7
1.7
ug/l
15.4
21.6
1.90
18
225
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
32
1.56
0.42
2.2
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
32
1.56
0.42
1.0
3.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
10
70
1.43
0.41
1.8
1.9
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
33
1.52
0.41
1.6
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
33
1.52
0.41
1.6
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
33
1.52
0.41
1.6
1.1
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
59
1.36
0.41
1.0
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
24
195
1.23
0.40
4.8
3.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
301
2863
1.06
0.40
1.6
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
18
227
0.79
0.40
1.2
1.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
13
97
1.34
0.39
1.0
1.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
5
35
1.43
0.39
2.2
3.0
ml/dl
14.5
15.1
—
5
30
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
36
1.39
0.38
1.6
3.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
170
0.76
0.38
1.0
1.1
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
9
67
1.34
0.38
10.6
7.5
mmol/l
26.7
25.2
—
9
61
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
26
312
0.83
0.38
1.4
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
48
420
1.15
0.38
2.6
2.6
%
16.4
16.2
0.06
28
218
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
14
107
1.31
0.37
1.2
1.7
mmol/l
6.2
7.9
—
5
65
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
37
1.35
0.37
1.0
1.5
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
9
70
1.29
0.36
2.9
2.5
%
28.8
27.6
—
9
63
(3033705) Calcium.ionized [Moles/volume] in Venous blood
29
244
1.19
0.36
2.6
2.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
22
267
0.82
0.36
1.4
1.5
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
22
180
1.22
0.36
2.8
4.7
u/ml
390.5
44.6
—
7
51
(3040151) Glucose [Moles/volume] in Capillary blood
26
217
1.20
0.35
3.6
6.3
mmol/l
6.7
7.3
0.38
20
182
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
48
423
1.14
0.35
2.0
3.3
u/ml
12.8
963.2
0.94
39
395
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
43
1.40
0.35
1.2
1.0
mmol/l
22.0
20.2
—
6
35
(21494434) Karyotype in Bone marrow
24
199
1.21
0.35
1.1
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
244
0.82
0.35
1.1
1.1
u/ml
2.4
5.0
0.77
12
104
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
27
227
1.19
0.34
1.7
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
42
478
0.88
0.34
1.4
1.4
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
142
1328
1.07
0.33
1.3
1.3
—
—
—
0
0
(44813793)
17
136
1.25
0.33
1.1
1.0
—
—
—
0
0
(4146454)
27
228
1.19
0.33
3.3
2.6
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
29
247
1.18
0.33
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
44
388
1.14
0.32
1.4
1.4
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
30
349
0.86
0.32
1.1
1.1
u/ml
2.7
5.2
1.10
16
191
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
19
155
1.23
0.32
1.6
1.7
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
63
696
0.90
0.32
1.4
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
52
1.35
0.31
1.4
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
74
676
1.10
0.31
2.9
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
111
1.26
0.30
1.2
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
111
1.26
0.30
1.2
1.9
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
67
611
1.10
0.29
1.4
1.4
ug/g
286.6
284.4
0.03
42
350
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
255
2443
1.05
0.29
2.0
1.8
%
1.5
1.5
0.24
230
2131
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
57
1.23
0.29
1.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
8
110
0.73
0.28
1.1
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
44
492
0.89
0.28
2.4
2.4
ug/min
51.5
126.6
1.99
31
307
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
64
584
1.10
0.28
1.3
1.3
miu/ml
154.9
217.3
0.66
22
264
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
29
333
0.87
0.28
1.0
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
658
6432
1.03
0.27
3.3
3.2
mmol/l
7.7
7.5
0.48
562
5432
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
42
375
1.12
0.27
1.6
1.4
u/ml
100.2
119.0
—
10
66
(3027008) Opiates [Presence] in Urine
79
730
1.08
0.27
2.8
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
300
1.14
0.26
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
36
405
0.89
0.26
2.9
3.2
nmol/l
0.7
0.8
1.64
21
320
(3013166) Neutrophils/100 leukocytes in Synovial fluid
8
67
1.19
0.26
1.3
1.3
%
62.3
56.1
—
8
58
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
61
558
1.10
0.26
1.1
1.1
u/ml
4.8
5.1
—
9
70
(3051593) INR in Capillary blood by Coagulation assay
11
86
1.28
0.26
6.1
13.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
180
1716
1.05
0.26
4.2
4.1
%
0.9
0.9
0.02
56
496
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
16
132
1.21
0.25
2.6
2.3
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
9
72
1.25
0.25
2.8
2.5
%
3.3
10.6
—
9
63
(3028300) Cannabinoids [Presence] in Urine
79
733
1.08
0.25
2.8
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
76
704
1.08
0.25
1.1
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
9
74
1.22
0.25
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
266
0.86
0.25
1.1
1.1
u/ml
1.2
3.0
1.10
12
106
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
84
0.71
0.24
3.3
1.9
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
23
265
0.87
0.24
1.4
1.5
g/l
33.4
32.1
0.21
23
235
(3042111) Morphology [Interpretation] in Bone marrow Narrative
38
341
1.12
0.23
1.3
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
13
158
0.82
0.23
1.2
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
112
1057
1.06
0.23
1.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
143
1.19
0.23
1.1
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
92
0.76
0.22
1.1
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
12
146
0.82
0.22
1.6
1.4
g/l
0.9
1.0
0.09
12
146
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
14
116
1.21
0.22
3.8
6.5
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
3.6
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
2.5
—
0
11
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
11
0.00
0.21
0.0
4.1
—
141.8
—
0
11
(3007542) Rye IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3022475) Manganese [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
21
182
1.16
0.21
1.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
21
182
1.16
0.21
1.5
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
21
182
1.16
0.21
1.5
1.6
—
—
—
0
0
(3013762) Body weight Measured
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
8
104
0.77
0.21
1.6
1.4
umol/l
11.4
23.9
—
8
96
(3032057) Clostridioides difficile [Presence] in Stool
5
43
1.16
0.21
1.2
1.8
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
223
2152
1.04
0.21
4.0
3.3
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
32
287
1.12
0.20
2.1
2.0
—
3.4
—
0
5
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
53
489
1.09
0.20
1.8
1.7
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
1.9
—
0
8
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(4133840)
6
48
1.25
0.20
1.3
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
40
438
0.91
0.20
2.6
1.9
nmol/l
0.9
0.8
0.17
34
362
(3000764) Benzodiazepines [Presence] in Urine
77
723
1.07
0.20
2.9
1.9
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
54
501
1.08
0.19
1.8
1.6
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
20
228
0.88
0.19
1.1
1.0
u/ml
0.1
0.4
—
5
64
(3005322) IgE [Units/volume] in Serum or Plasma
125
1308
0.95
0.19
1.3
1.3
u/ml
143.5
216.7
1.22
114
1204
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
137
1.17
0.18
1.0
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
609
5986
1.02
0.18
3.1
3.3
mg/l
330.4
294.7
0.08
383
3786
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
48
444
1.08
0.18
1.4
1.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
45
415
1.09
0.18
4.7
5.2
iu/ml
170.1
814.8
—
7
51
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
17
147
1.16
0.18
2.5
2.3
%
16.7
13.9
—
9
62
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
19
166
1.15
0.18
1.9
2.3
u/field
1.1
2.0
—
8
73
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
10
121
0.83
0.18
1.3
1.3
—
1.4
—
0
7
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
60
1.17
0.17
2.4
2.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
161
1671
0.96
0.17
4.6
3.8
mmol/l
1.2
1.2
0.12
151
1441
(1761482) Bacteria [#/volume] in Urine by Culture
54
504
1.07
0.17
4.5
4.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
17
148
1.15
0.17
2.5
2.3
%
79.5
72.4
1.44
17
140
(3035933) Granulocytes/100 leukocytes in Blood
5
69
0.72
0.17
1.8
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
219
2125
1.03
0.16
2.2
2.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
60
563
1.07
0.16
3.3
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
35
321
1.09
0.16
2.1
1.9
mmol/l
1.8
1.7
0.29
35
315
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
139
1.15
0.16
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
71
1.13
0.16
1.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
76
720
1.06
0.16
2.9
1.9
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
72
1.11
0.16
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
73
1.10
0.15
1.0
1.0
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
17
193
0.88
0.15
1.4
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
10
119
0.84
0.15
1.0
1.1
—
—
—
0
0
(44806118)
27
245
1.10
0.15
1.9
1.5
—
—
—
0
0
(44790048)
27
245
1.10
0.15
1.9
1.5
—
—
—
0
0
(44790047)
27
245
1.10
0.15
1.9
1.5
—
—
—
0
0
(44790049)
27
245
1.10
0.15
1.9
1.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
31
338
0.92
0.15
1.1
1.1
u/ml
0.4
1.4
1.05
14
159
(3004775) Volume in Urine collected for unspecified duration
18
159
1.13
0.15
2.0
2.3
ml
687.8
627.7
0.44
12
104
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
304
1.09
0.14
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
160
1.13
0.14
1.4
1.3
u/ml
0.4
0.6
0.24
12
71
(3006653) Thiamine [Moles/volume] in Blood
12
103
1.17
0.13
1.2
1.3
nmol/l
132.6
140.5
0.37
12
103
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
98
0.82
0.13
1.0
1.0
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
99
0.81
0.13
1.1
1.6
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
24
218
1.10
0.13
1.5
2.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
44
414
1.06
0.12
1.6
1.4
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
20
181
1.11
0.12
1.7
2.1
—
1.8
—
0
10
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
47
444
1.06
0.11
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
57
542
1.05
0.11
1.1
1.2
titre
74.3
94.4
—
7
41
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
320
3144
1.02
0.11
1.3
1.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
44
466
0.94
0.11
1.3
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
52
495
1.05
0.10
4.7
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
58
554
1.05
0.10
1.1
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
31
331
0.94
0.10
1.2
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
17
187
0.91
0.10
1.1
1.2
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
37
392
0.94
0.10
1.1
1.1
u/ml
0.9
2.2
0.75
14
178
(4010399)
150
1464
1.03
0.09
1.5
1.4
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
46
1.09
0.09
4.6
2.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
31
330
0.94
0.09
1.2
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
185
1889
0.98
0.09
1.4
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
13
116
1.12
0.09
1.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
11
97
1.13
0.09
1.2
1.3
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
54
1.11
0.09
8.8
4.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
31
329
0.94
0.09
1.4
1.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
56
1.07
0.08
1.5
1.1
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
6
57
1.05
0.08
2.8
1.6
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
62
597
1.04
0.08
1.4
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
12
107
1.12
0.08
2.3
1.6
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
5
61
0.82
0.08
1.0
1.3
mmol/l
1.8
3.2
—
5
53
(4015189)
5
62
0.81
0.08
4.4
2.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
5
63
0.79
0.08
1.6
1.7
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
29
273
1.06
0.08
2.3
2.7
—
—
—
0
0
(1002224) Polysomnography panel
84
816
1.03
0.07
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
72
0.83
0.07
3.0
1.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
167
1639
1.02
0.07
4.2
4.1
%
0.1
0.1
0.04
50
460
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
6
74
0.81
0.07
1.3
1.2
%
114.8
109.9
—
6
64
(3020682) Albumin/Creatinine [Ratio] in Urine
634
6290
1.01
0.07
3.7
4.0
mg/mmol
10.0
9.1
0.07
391
3978
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
2.5
2.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
43
412
1.04
0.07
1.6
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
84
0.83
0.07
1.3
2.0
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
245
1.06
0.07
1.7
1.5
%
65.9
61.9
0.24
18
151
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
9
84
1.07
0.07
1.3
1.4
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.3
1.9
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
9
87
1.03
0.07
1.3
1.9
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
225
2218
1.02
0.07
1.6
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
88
1.02
0.07
5.0
4.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
23
216
1.07
0.06
1.1
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
275
1.06
0.06
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
19
177
1.07
0.06
1.1
1.3
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
195
1921
1.02
0.06
2.1
2.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
11
99
1.11
0.06
2.8
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
46
443
1.04
0.06
4.1
3.6
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
20
187
1.07
0.06
3.2
3.1
mg/l
34.9
39.7
0.08
13
141
(3012501) Base excess in Blood by calculation
48
463
1.04
0.06
9.4
4.4
mmol/l
3.5
2.6
1.28
37
321
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
355
1.04
0.06
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
63
648
0.97
0.06
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
233
0.94
0.05
1.3
1.3
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
48
464
1.04
0.05
9.4
4.4
kpa
5.2
5.1
0.33
48
459
(3027315) Oxygen [Partial pressure] in Blood
48
464
1.04
0.05
9.4
4.5
kpa
8.3
8.5
0.35
48
459
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
41
395
1.04
0.05
1.4
1.3
u/ml
210.8
253.6
0.82
31
229
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
257
1.05
0.05
1.1
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
33
344
0.96
0.05
1.7
1.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
75
767
0.98
0.05
1.6
1.6
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
413
0.97
0.04
5.0
3.6
%
57.6
57.6
0.01
40
413
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
546
5431
1.01
0.04
1.7
1.7
mmol/l
1.4
1.4
0.27
474
4547
(3016750) Collection duration of Urine
13
121
1.07
0.03
1.4
2.0
min
482.1
496.0
—
8
87
(3023511) Choriogonadotropin [Units/volume] in Urine
32
331
0.97
0.03
1.6
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
67
657
1.02
0.03
1.3
1.3
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
38
369
1.03
0.03
2.1
1.7
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
38
391
0.97
0.03
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
28
270
1.04
0.03
1.5
1.5
—
—
—
0
0
(3011648) Oxygen content in Venous blood
18
171
1.05
0.03
4.7
4.1
%
10.8
11.4
0.25
18
171
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
1.3
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
1.3
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
1.3
1.8
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
10
108
0.93
0.03
1.3
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
32
311
1.03
0.02
1.5
1.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
34
331
1.03
0.02
3.2
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
41
419
0.98
0.02
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
173
1718
1.01
0.02
1.6
1.7
—
—
—
0
0
(3000492) Spirometry study
197
1958
1.01
0.02
1.5
1.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
159
1579
1.01
0.02
3.8
3.9
%
0.6
0.6
0.11
40
362
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
67
679
0.99
0.01
2.5
2.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
541
5423
1.00
0.01
4.0
3.3
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
21
217
0.97
0.01
1.8
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
153
1539
0.99
0.01
4.2
4.2
%
0.0
0.5
0.87
43
390
(40768441) Liver Pathology biopsy report
14
146
0.96
0.00
1.1
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
10
101
0.99
0.00
2.2
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
129
1.01
0.00
1.5
1.5
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
18
181
0.99
0.00
2.6
2.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
40
399
1.00
0.00
4.5
3.4
e9/l
4.4
4.2
0.11
40
399
(3006922) Hepatitis E virus Ab [Presence] in Serum
11
114
0.96
0.00
1.0
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
116
1.03
0.00
1.2
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
12
124
0.97
0.00
1.2
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
18
184
0.98
0.00
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
11
108
1.02
0.00
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
11
108
1.02
0.00
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
13
128
1.02
0.00
1.6
3.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
14
138
1.01
0.00
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
17
172
0.99
0.00
1.2
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
172
1716
1.00
0.00
2.9
2.9
ng/l
135.4
196.3
1.91
152
1557
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
117
1.03
0.00
1.2
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
10
103
0.97
0.00
1.5
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
20
203
0.99
0.00
1.4
1.5
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.6
—
30.6
—
0
8
(3013862) HLA-DP [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.1
—
3.7
—
0
8
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
9
89
1.01
0.00
1.3
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
11
110
1.00
0.00
1.6
1.6
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
9
89
1.01
0.00
1.3
1.4
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
9
0.00
0.00
0.0
5.1
—
—
—
0
0
(3024471) HLA-A [Type]
6
64
0.94
0.00
1.0
1.0
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
2.7
—
0
6
(21494814) CD8 cells/100 lymphocytes in Specimen
8
80
1.00
0.00
2.3
2.0
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
7
73
0.96
0.00
1.3
2.6
—
37721.9
—
0
12
(3012989) Citrate [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.5
—
2.4
—
0
6
(4198724)
8
81
0.99
0.00
1.6
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
58
0.86
0.00
1.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
86
0.93
0.00
1.1
1.2
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
6.1
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
11
110
1.00
0.00
1.6
1.6
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
9
89
1.01
0.00
1.3
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
72
0.97
0.00
1.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
274.8
—
0
5
(3024932) HLA-DR beta [Type]
6
63
0.95
0.00
1.2
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
6
0.00
0.00
0.0
1.0
—
4.6
—
0
6
(3016135) IgD [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
150.7
—
0
5
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
26.0
—
0
7
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
86
0.93
0.00
1.3
1.1
iu/ml
175.9
208.6
—
8
86
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BRAIN_CNS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_CNS | 1.426 [1.28, 1.59] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.067 |
During the follow-up period (1.1.1998 — 31.12.2019), 1002 out of 6194 females with CD2_BENIGN_BRAIN_CNS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_CNS | 1.535 [1.36, 1.73] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 982 out of 5169 males with CD2_BENIGN_BRAIN_CNS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BRAIN_CNS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.151% | 0.282% |
| 5 | 0.758% | 1.884% |
| 10 | 1.852% | 4.34% |
| 15 | 3.776% | 7.947% |
| 20 | 6.515% | 13.483% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_CNS – Benign neoplasm of brain and other parts of central nervous system
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data